The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 1999;341(24):1864.

Original Article
Volume 341:1485-1490 November 11, 1999 Number 20
NextNext

Prevention of Neural-Tube Defects with Folic Acid in China
Robert J. Berry, M.D., M.P.H.T.M., Zhu Li, M.D., M.P.H., J. David Erickson, D.D.S., Ph.D., Song Li, M.D., Cynthia A. Moore, M.D., Ph.D., Hong Wang, M.D., Ph.D., Joseph Mulinare, M.D., M.S.P.H., Ping Zhao, M.D., Lee-Yang C. Wong, M.S., Jacqueline Gindler, M.D., Shi-Xin Hong, M.D., Adolfo Correa, M.D., Ph.D., for The China–U.S. Collaborative Project for Neural Tube Defect Prevention

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
ABSTRACT

Background Periconceptional use of multivitamins containing folic acid can reduce a woman's risk of having a baby with a neural-tube defect.

Methods As part of a public health campaign conducted from 1993 to 1995 in an area of China with high rates of neural-tube defects (the northern region) and one with low rates (the southern region), we evaluated the outcomes of pregnancy in women who were asked to take a pill containing 400 µg of folic acid alone daily from the time of their premarital examination until the end of their first trimester of pregnancy.

Results Among the fetuses or infants of 130,142 women who took folic acid at any time before or during pregnancy and 117,689 women who had not taken folic acid, we identified 102 and 173, respectively, with neural-tube defects. Among the fetuses or infants of women who registered before their last menstrual period and who did not take any folic acid, the rates of neural-tube defects were 4.8 per 1000 pregnancies of at least 20 weeks' gestation in the northern region and 1.0 per 1000 in the southern region. Among the fetuses or infants of the women with periconceptional use of folic acid, the rates were 1.0 per 1000 in the northern region and 0.6 per 1000 in the southern region. The greatest reduction in risk occurred among the fetuses or infants of a subgroup of women in the northern region with periconceptional use who took folic acid pills more than 80 percent of the time. In the southern region the reduction in risk among the fetuses or infants of women with periconceptional use of folic acid was also significant (reduction in risk, 41 percent; 95 percent confidence interval, 3 to 64 percent).

Conclusions Periconceptional intake of 400 µg of folic acid daily can reduce the risk of neural-tube defects in areas with high rates of these defects and in areas with low rates.


Source Information

From the Birth Defects and Genetic Diseases Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta (R.J.B., J.D.E., C.A.M., J.M., L.-Y.C.W., J.G., A.C.); and the National Center for Maternal and Infant Health and the Department of Health Care Epidemiology, Beijing Medical University, Beijing, China (Z.L., S.L., H.W., P.Z., S.-X.H.). Other authors were Ling Hao, M.D., M.P.H. (National Center for Maternal and Infant Health and the Department of Health Care Epidemiology, Beijing Medical University, Beijing, China), and Elaine Gunter, B.S., M.T.(A.S.C.P.) (Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta).

Address reprint requests to Dr. Berry at the Birth Defects and Genetic Diseases Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Hwy., MS F-45, Atlanta, GA 30341-3724.

Full Text of this Article


Related Letters:

Neural-Tube Defects
Schulman J. D., Werler M. M., Mitchell A. A., Hook E. B., Botto L. D., Erickson J. D., Mulinare J., Berry R. J., Gindler J., Botto L.
Extract | Full Text  
N Engl J Med 2000; 342:1135-1137, Apr 13, 2000. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.